Targeting fibroblast growth factor receptor and discoidin domain receptor 2 in non-small-cell lung cancer

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S385-6. doi: 10.1097/JTO.0b013e31826df166.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Clinical Trials as Topic
  • Discoidin Domain Receptors
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism
  • Molecular Targeted Therapy*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Receptors, Fibroblast Growth Factor / antagonists & inhibitors*
  • Receptors, Fibroblast Growth Factor / metabolism
  • Receptors, Mitogen / antagonists & inhibitors*
  • Receptors, Mitogen / metabolism

Substances

  • Antineoplastic Agents
  • Receptors, Fibroblast Growth Factor
  • Receptors, Mitogen
  • Discoidin Domain Receptors
  • Receptor Protein-Tyrosine Kinases